| 000 | 01809 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513084205.0 | ||
| 264 | 0 | _c19960222 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a0039-2499 | ||
| 024 | 7 |
_a10.1161/01.str.27.1.76 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDiener, H C | |
| 245 | 0 | 0 |
_aLubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group. _h[electronic resource] |
| 260 |
_bStroke _cJan 1996 |
||
| 300 |
_a76-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarotid Artery Diseases _xtherapy |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
| 700 | 1 | _aHacke, W | |
| 700 | 1 | _aHennerici, M | |
| 700 | 1 | _aRådberg, J | |
| 700 | 1 | _aHantson, L | |
| 700 | 1 | _aDe Keyser, J | |
| 773 | 0 |
_tStroke _gvol. 27 _gno. 1 _gp. 76-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.27.1.76 _zAvailable from publisher's website |
| 999 |
_c8552482 _d8552482 |
||